The Russian Health Ministry reported that the first batch of the country’s COVID-19 vaccine – Sputnik V – has been released into civil circulation. The Ministry further noted that the vaccine that has been jointly developed by the Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) had passed all required quality tests in the laboratories of Roszdravnadzor, a Russian medical device regulator.
Furthermore, as reported by ANI, the health ministry has stated that the “the delivery of the first batches of the Russian vaccine [Sputnik V] to the country’s regions is planned in the nearest future.”
On 11th August 2020, Russia became the first country to register a COVID-19 vaccine. However, this announcement was met with a lot of backlash and scepticism in the void of proper clinical trials. Nevertheless, twenty countries, including India, UAE, Brazil and Saudi Arabia signed a contract for the controversial vaccine.
On Monday, Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), confirmed that India and some other countries would commence the Sputnik V vaccine trials in this month. Dmitriev told ANI:
Reports claim that Russia will produce about six million doses of the inoculation per month. Its partnership with countries like India is of key importance because India is the largest vaccine manufacturer in the world.
On Friday, the preliminary result of the vaccine was published in the journal the Lancet. The findings stated that in small human trials, the vaccine successfully produced an antibody response without any side-effects.